Travere Therapeutics, Inc. (TVTX)

NASDAQ: TVTX · Real-Time Price · USD

65.67

-1.85 (-2.74%)

At close: Aug 28, 2026, 4:00 PM EDT

65.21

-0.46 (-0.70%)

Pre-market: Aug 31, 2026, 5:11 AM EDT

Travere Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	591.33	490.73	233.18	145.24	109.46	131.84
Revenue Growth	77.12%	110.45%	60.55%	32.69%	-16.97%	-33.52%
Gross Profit	350.12	274.38	7.94	-111.2	-122.29	-73.14
Operating Income	-40.46	-62.82	-256.18	-376.74	-319.81	-199.43
Net Income	-43.46	-25.55	-321.55	-111.4	-278.48	-180.09
Earnings Per Share	-0.48	-0.29	-4.08	-1.50	-4.37	-3.01
EPS Growth	-	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	489.18	322.8	370.7	566.85	450.25	552.88
Total Debt	616.91	328.73	401.58	404.78	407.49	261.99
Net Cash (Debt)	-127.73	-5.94	-30.88	162.07	42.76	290.9
Net Cash Growth	-	-	-	279.04%	-85.30%	147.45%
Net Cash Per Share	-1.40	-0.07	-0.39	2.18	0.67	4.86

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	92.7	37.78	-237.48	-280.02	-186.29	-14.79
Capital Expenditures	-	-	-	-	-	-5.1
Free Cash Flow	92.7	37.78	-237.48	-280.02	-186.29	-19.89
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	59.21%	55.91%	3.40%	-76.57%	-111.72%	-55.48%
Operating Margin	-6.84%	-12.80%	-109.87%	-259.40%	-292.17%	-151.27%
Pretax Margin	-11.34%	-10.04%	-137.45%	-258.96%	-302.54%	-164.51%
Profit Margin	-7.35%	-5.21%	-137.90%	-76.70%	-254.41%	-136.60%
FCF Margin	15.68%	7.70%	-101.84%	-192.80%	-170.19%	-15.09%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	16.74	38.08	42.85	42.85	42.85	42.85
P/FCF Ratio	66.78	90.48	-	-	-	-
PS Ratio	10.47	6.97	6.50	4.65	12.33	14.42